N-Propionitrile Brorphine Detected in New York: What Families Need to Know About This Emerging Synthetic Opioid

The New York State Department of Health has issued an urgent public health alert about a dangerous new synthetic opioid appearing in the state's drug supply. N-Propionitrile Brorphine, a lab-created chemical compound, was identified by the state's drug checking program on June 25, 2026, from a sample collected in April.

This detection marks the latest development in an ongoing challenge: the rapid emergence of new synthetic opioids that evade existing drug laws and complicate overdose response efforts. For families concerned about substance use, understanding what this means—and what hasn't changed about protecting loved ones—is essential.

What Is N-Propionitrile Brorphine?

N-Propionitrile Brorphine belongs to a class of synthetic opioids known as "orphines," which are chemically distinct from both traditional opiates (derived from the poppy plant) and fentanyl analogues. The substance is manufactured in laboratories, not derived from natural sources.

State health officials note that the exact potency of N-Propionitrile Brorphine remains unknown because the substance is so new. However, it structurally resembles other orphine compounds that are significantly more potent than fentanyl. For context, fentanyl itself is approximately 50-100 times more potent than morphine.

Dr. Chinazo Cunningham, Commissioner of the New York State Office of Addiction Services and Supports, emphasized the concerning nature of this discovery: "This is not going away. This will continue to happen because things made in a lab are an easy way to sort of introduce new substances into the drug supply."

How Was It Discovered?

The detection came through New York's drug checking program, which analyzes substances collected from various sources across the state. The sample containing N-Propionitrile Brorphine was collected in April 2026, with laboratory identification completed by late June.

Importantly, the substance was found in combination with fentanyl—a common pattern with emerging synthetics. Drug suppliers often mix new compounds with established substances like fentanyl, either to enhance effects or to circumvent legal restrictions on known substances.

The Challenge of Detection

A critical concern with N-Propionitrile Brorphine is that standard drug testing cannot detect it. As Dr. Cunningham explained: "It's a bit of a cat and mouse game where then the healthcare system and the law enforcement system is really scrambling to try and get things in place so that we can detect it and can understand it better, but that is not in place right now."

This means:

• Hospital toxicology screens won't identify it — standard emergency department drug panels test for common substances like fentanyl, heroin, cocaine, and prescription opioids, but cannot detect novel synthetic compounds
• Fentanyl test strips won't detect it — these strips only react to fentanyl and some of its known analogues
• Users cannot know if their supply contains it — there's no at-home test currently available for this specific compound

What Does This Mean for Overdose Response?

Despite the unknown potency and undetectable nature of N-Propionitrile Brorphine, the fundamental approach to overdose response remains unchanged: naloxone (Narcan) is still effective.

Naloxone works by binding to opioid receptors in the brain, displacing other opioids and reversing the life-threatening respiratory depression that causes overdose deaths. Because N-Propionitrile Brorphine is an opioid agonist (it activates opioid receptors), naloxone can reverse its effects.

However, given the potentially high potency of this substance, multiple doses of naloxone may be necessary. Dr. Cunningham advises:

1. Administer one dose of naloxone (4mg nasal spray or 0.4mg injection)
2. Wait 2-3 minutes to assess response
3. Administer a second dose if there's no response
4. Call 911 immediately — even if the person responds to naloxone, they need medical evaluation

New York's Good Samaritan law protects anyone who calls 911 during an overdose from arrest or prosecution for drug possession.

Broader Context: The "Orphine" Class of Synthetic Opioids

N-Propionitrile Brorphine is part of a growing family of synthetic opioids that have emerged in recent years. The original compound in this class, simply called "brorphine," was temporarily placed in Schedule I by the DEA in 2021 and permanently scheduled in 2023.

Since then, chemists have created numerous analogues—slightly modified versions designed to evade legal restrictions while maintaining or enhancing potency. Other recent orphine variants that have triggered federal action include:

• Cychlorphine (N-propionitrile chlorphine)
• 5,6-dichloro brorphine
• 5,6-dichloro desmethylchlorphine
• Spirochlorphine

In July 2026, the DEA filed notices of intent to temporarily place these four compounds in Schedule I, recognizing their potential for abuse and danger to public health.

What Families Should Know

For Those with Loved Ones Using Substances

The basics of harm reduction remain the same:

• Never use alone — have someone nearby who can call 911 and administer naloxone
• Carry naloxone and know how to use it — New York residents can obtain free naloxone by mail through Prevent Overdose RI or at pharmacies throughout the state
• Start with a small amount when using an unfamiliar supply
• Avoid mixing substances — combining opioids with alcohol, benzodiazepines, or stimulants dramatically increases overdose risk

Additional precautions given the current situation:

• Be extra cautious with any supply — since N-Propionitrile Brorphine cannot be detected, assume any illicit opioid supply could contain unknown potent synthetics
• Use overdose prevention centers where available — New York City operates the nation's first state-sanctioned overdose prevention centers, where trained staff can respond immediately to overdoses
• Consider medication-assisted treatment (MAT) — buprenorphine, methadone, and naltrexone reduce overdose risk by providing a regulated, known-dose alternative to the unpredictable illicit supply

For Those in Recovery

If you or a loved one is in recovery from opioid use disorder, this news may be triggering. Remember:

• This information is not a reason to panic — it's a reminder of why recovery matters and why the work you're doing is important
• Stay connected to your support system — reach out to sponsors, counselors, or support groups if this news causes anxiety
• Naloxone is still relevant in recovery — people in recovery can still be at risk of overdose if they return to use, especially after periods of abstinence when tolerance has decreased

Prescription Safety

Dr. Cunningham emphasized an important point: "For this strain, there's no chance of it getting into your prescription drugs. But as for anything bought on the street, she has a warning."

Prescription medications obtained from licensed pharmacies remain safe. The danger lies exclusively in the unregulated illicit drug supply. This underscores the importance of:

• Only using medications prescribed to you
• Obtaining medications exclusively from licensed pharmacies
• Never sharing prescription medications
• Properly disposing of unused medications through take-back programs

What New York Is Doing

The New York State Department of Health has taken several steps in response to this detection:

1. Issued a public health advisory to healthcare providers, harm reduction programs, and the public
2. Expanded drug checking surveillance to monitor for the spread of this substance
3. Coordinated with local health departments to ensure naloxone availability and training

The state maintains a map of naloxone access points throughout Monroe County and similar resources are available in other counties.

Looking Ahead

The emergence of N-Propionitrile Brorphine illustrates a fundamental challenge in addressing the overdose crisis: the illicit drug supply is constantly evolving. As authorities identify and regulate one substance, new variants appear.

For families, this reality can feel overwhelming. But the core protective strategies—naloxone access, never using alone, and connecting loved ones to treatment—remain effective regardless of what specific substance is in the supply.

If you're concerned about a loved one's substance use, the SAMHSA National Helpline (1-800-662-4357) provides free, confidential, 24/7 treatment referral and information. You can also use their online treatment locator to find providers in your area.

This alert was medically reviewed by Dr. Rachel Bennett, MD, a board-certified addiction medicine physician. The information provided is for educational purposes and does not constitute medical advice. In case of emergency, call 911 immediately.